About: Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. was founded in 2007 and is headquartered in Yardley, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Latest price: $4.22 (-7.05%)
SVRA NASDAQ Savara Inc
Savara Inc share price
Atividade de preço de SVRA
Último preço
$ 4,220
Variação (24h)
-0,32 USD (7,05%)
Volume
2.82M
Volume (média 4 sem.)
-
Abertura
$ 4,52
Variação do dia
$ 4,13 - $ 4,58
Fechamento anterior
$ 4,54
Último negócio
23 Oct, 8:27 pm GMT+0
Atrasado
23 Oct, 8:27 pm GMT+0
SVRA price performance
Atrasado
23 Oct, 8:27 pm GMT+0
quote.marketSignals